⌘K

Login Start Free

Home/Filings/4/0001562180-18-001353

4//SEC Filing

Baker Mark Robert 4

Accession 0001562180-18-001353

CIK 0000835887other

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 1:08 PM ET

Size

5.3 KB

Accession

0001562180-18-001353

Insider Transaction Report

Form 4

Period: 2018-03-01

PROGENICS PHARMACEUTICALS INCPGNX

Baker Mark Robert

General Counsel

Transactions

Award
Non-Qualified Stock Option (Right to Buy)
2018-03-01+201,250→ 201,250 total
Exercise: $6.62Exp: 2028-03-01→ Common Stock (201,250 underlying)

Footnotes (1)

[F1]3yr 33% On Vest beginning on 01-Mar-2018

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeother

Related Parties

1

filerCIK 0001331438

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 1:08 PM ET
Size: 5.3 KB

View on SEC.gov